RxDoctor Payments Data

Heather Kohli-Werner, PA

Physician Assistant · Berlin, MDNPI 1720319452

Payments from drug & device makers

$534in general payments, 2019–2025

Across 28 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$97
  • Pfizer$90
  • Novo Nordisk$82
  • AbbVie$71
  • GSK$38
  • Amgen$38
  • plus $118 from 6 others

What the payments were for

  • Food & beverage$534100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$534 in reported general payments places this provider in the 70th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$167,190
Medicare patients
436
Services billed
3,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin71$78,654
OzempicSemaglutide71$71,361
MounjaroTirzepatide32$40,816
TrulicityDulaglutide22$39,115
RybelsusSemaglutide22$34,660
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$25,421
JanuviaSitagliptin Phosphate18$22,691
XareltoRivaroxaban16$15,369
Rosuvastatin Calcium414$10,266
Atorvastatin Calcium568$6,568
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,977
Albuterol Sulfate HfaAlbuterol Sulfate138$5,772
VascepaIcosapent Ethyl12$5,742
Ezetimibe85$5,623
Humalog Kwikpen U-100Insulin Lispro12$5,283

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$82$106,02193 claims
Lilly USA, LLCMounjaro, Trulicity$97$79,93154 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$38$36,44152 claims
AbbVieSynthroid$71$3,32344 claims
PfizerPaxlovid$90$1,38012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Berlin

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →